- Home
- » Tags
- » Dacarbazine
Top View
- High-Dose Busulphan/Melphalan with Autologous Stem Cell Rescue in Ewing’S Sarcoma
- Diamminedichloroplatinum in Malignant Mesothelioma1
- Uterine Sarcoma Treatment Regimens
- How to Order Chemotherapy at Shands at the University of Florida - Inpatient
- HOPA News Volume 10, Issue 1
- Eribulin Versus Dacarbazine in Patients with Leiomyosarcoma: Subgroup Analysis from a Phase 3, Open-Label, Randomised Study
- Emetogenic Potential of Antineoplastic Agents
- Computationally Predicting Clinical Drug Combination Efficacy With
- DBL™ Dacarbazine for Injection Name of Medicine Dacarbazine
- Hodgkin's Disease
- Chemotherapy
- Adult Antiemetic Management of Chemotherapy-Induced Nausea
- Fertility Following Contemporary Chemotherapy in Childhood Cancer Survivors
- North Carolina Division of Health Benefits Physician Administered Drug Program Catalog
- A Phase I Dose-Escalation Study of Selumetinib in Combination with Docetaxel Or Dacarbazine in Patients with Advanced Solid Tumors Patricia M
- Package Leaflet: Information for the Patient
- Skin Pathway Group – CVD (Cisplatin, Vinblastine, Dacarbazine) in Melanoma
- Beacopdac Escalated)
- Resistance of Uveal Melanoma to the Interstrand Cross-Linking Agent Mitomycin C Is Associated with Reduced Expression of CYP450R
- Dacarbazine for Injection, USP
- Guideline for Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients
- Data Sheet Template
- DRUG NAME Toxicities: Acute: Delayed: Subclass Mechanism of Action
- Rescue Protocols for Canine Lymphoma
- Sarcoma and Pnet
- Cancer Drug Costs for a Month of Treatment at Initial Food and Drug
- Dacarbazine Monograph
- SOFT TISSUE SARCOMA TREATMENT REGIMENS (Part 1 of 2)
- The Pharmacologic Basis of High Dose Chemotherapy with Haematopoietic Stem Cell Support for Solid Tumours
- BC Cancer Protocol Summary for Treatment of Hodgkin Lymphoma
- Vivida Health Specialty Pharmacy Drugs (Injectable) Prior-Authorization Requirements Effective 1/1/19
- MELANOMA TREATMENT REGIMENS (Part 1 of 2) the Selection, Dosing, and Administration of Anticancer Agents and the Management of Associated Toxicities Are Complex
- Doxorubicin Plus Dacarbazine, Doxorubicin Plus Ifosfamide, Or
- Full Text (PDF)
- Hazardous Drug List
- Dacarbazine Property Information Molecular Weight 182.2A CAS No
- Radiation Recall Phenomenon Associated with Arsenic Trioxide
- Medications That Are Considered Hazardous
- Antineoplastic Drugs